Dehaier Receives CFDA Approval for DHR998 Sleep Diagnostic Device
10 January 2014 - 1:00AM
Dehaier Medical Systems Ltd. (Nasdaq:DHRM)
("Dehaier" or the "Company"), an emerging leader in the
development, assembly, marketing and sale of medical devices and
homecare medical products in China, announced that it has received
approval from the Chinese State Food and Drug Administration for
its second generation DHR998 Sleep Diagnostic Device. Dehaier has
now formed a comprehensive line of products to address the market
demands of sleep diagnosis, sleep apnea treatment and CPAP
treatment evaluation. This product portfolio should be introduced
for sale in early 2014.
Mr. Chen, Dehaier's CEO and President, remarked "our new DHR998
Sleep Diagnostic Device is a technological upgrade based on
Dehaier's original high efficiency sleep diagnostic and monitoring
product. The new device improves upon its predecessor with an
enhanced and more user-friendly operating system and more accurate
respiratory analysis across five testing variables: PPG
(plethysmograph), oxygen saturation, heart rate, snoring and body
position. By using the Morpheus Ox System, the advanced automatic
sleep scoring software generates an accurate and reliable sleep
study diagnosis, including Apnea Hypopnea Index (AHI), sleep/wake
time, and Cheyne-Stokes breathing patterns. The new generation
Morpheus Ox is a comprehensive platform that manages a
cost-effective sleep services operation, including patient
electronic medical records, cardiac and sleep diagnostics outcomes
and complete workflow management. The web-based automatic scoring
and data management quickly gives users valuable clinical
information to improve patient treatment. We will start advertising
and selling these products in the first quarter of 2014."
About Dehaier Medical Systems
Ltd.
Dehaier is an emerging leader in the development, assembly,
marketing and sale of medical products, including respiratory and
oxygen homecare medical products. The company develops and
assembles its own branded medical devices and homecare medical
products from third-party components. The company also distributes
products designed and manufactured by other companies, including
medical devices from IMD (Italy), Welch Allyn (USA), HEYER
(Germany), Timesco (UK), eVent Medical (US) and JMS (Japan).
Dehaier's technology is based on six patents, ten software
copyrights and proprietary technology. More information may be
found at http://www.dehaier.com.cn
Forward-looking Statements
This news release contains forward-looking statements as defined
by the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include statements concerning plans,
objectives, goals, strategies, future events, government approvals
or performance, and underlying assumptions and other statements
that are other than statements of historical facts, including in
particular any implications regarding the new DHR998 sleep
diagnostic device. These statements are subject to uncertainties
and risks including, but not limited to, product and service demand
and acceptance, changes in technology, economic conditions, the
impact of competition and pricing, government regulation, future
developments in payment for and demand for medical equipment and
services, implementation of and performance under the joint venture
agreement by all parties, and other risks contained in reports
filed by the company with the Securities and Exchange Commission.
All such forward-looking statements, whether written or oral, and
whether made by or on behalf of the company, are expressly
qualified by the cautionary statements and any other cautionary
statements which may accompany the forward-looking statements. In
addition, the company disclaims any obligation to update any
forward-looking statements to reflect events or circumstances after
the date hereof.
CONTACT: Dehaier Medical Systems Limited
Surie Liu
+86 10-5166-0080
lius@dehaier.com.cn
Dehaier Medical Systems Limited
Tina He
+86 10-5166-0080
hexw@dehaier.com.cn
Lianluo Smart (NASDAQ:LLIT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Lianluo Smart (NASDAQ:LLIT)
Historical Stock Chart
From Jul 2023 to Jul 2024